J&J aims to rely on innovation to make sustained gains in the Chinese market

Unlike most of its peers, Johnson & Johnson believes that it has the right formula for growth in China, notwithstanding the unique macroeconomic challenges particular to the region, including the country's sluggish economic growth.

No one knows this better than Jesse Wu, the chairman of Johnson & Johnson China. As the first local chairman of the US-based diversified healthcare giant, Wu has the formidable task of shepherding the company onto the path of sustainable development and achieving business expansion in China, amid complex challenges.